A Meddevicetracker report predicts the worldwide market for blood glucose monitoring devices will reach $7.5 billion by 2022 with a 2.4% compound annual growth rate. Last year, the market was led by Roche with a 29% market share, followed by Abbott Laboratories, LifeScan, Ascensia Diabetes Care, Dexcom and Medtronic.